Stereotaxis, Inc.
STXS- Exchange
- NYSE
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001289340
No open-market purchases or sales by Stereotaxis, Inc. insiders were filed in the last 90 days; 108 institutions reported holding it in 13F filings for Q2 2026, worth $74.1M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Stereotaxis, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- +5 vs. Q2 2021
- Shares held
- 42.9M
- −1.04M (−2.4%) vs. Q2 2021
- Total value
- $230.6M
- −$192.5M (−45.5%) vs. Q2 2021
- New holders
- 20
- 34 more added
- Sold out
- 15
- 33 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting STXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 108 | $74.1M |
| Q1 2026 | 115 | $79.0M |
| Q4 2025 | 105 | $98.3M |
| Q3 2025 | 104 | $130.3M |
| Q2 2025 | 87 | $86.3M |
| Q1 2025 | 88 | $69.6M |
| Q4 2024 | 86 | $94.0M |
| Q3 2024 | 84 | $82.5M |
| Q2 2024 | 73 | $73.2M |
| Q1 2024 | 81 | $105.7M |
| Q4 2023 | 61 | $65.2M |
| Q3 2023 | 58 | $59.9M |
| Q2 2023 | 59 | $61.1M |
| Q1 2023 | 68 | $69.9M |
| Q4 2022 | 74 | $73.8M |
| Q3 2022 | 71 | $65.1M |
| Q2 2022 | 85 | $67.3M |
| Q1 2022 | 93 | $150.1M |
| Q4 2021 | 97 | $263.4M |
| Q3 2021 | 104 | $230.6M |
| Q2 2021 | 99 | $423.1M |
| Q1 2021 | 81 | $291.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Stereotaxis, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 2,483,667 | $13.4M | 0.00% | −169,945−6.4% | Reduced |
| Opaleye Management Inc. | 2,526,500 | $13.6M | 2.54% | 00.0% | Unchanged |
| BlackRock Inc. | 3,296,946 | $17.7M | 0.00% | −13,740−0.4% | Reduced |
| DAFNA Capital Management LLC | 13,680,554 | $73.6M | 19.53% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,843,000−100.0% | Sold out |
| Calamos Advisors LLC | 0 | $0 | 0.00% | −660,818−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −452,112−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −342,282−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −115,037−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −43,643−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,665−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Hancock Whitney Corp | 0 | $0 | 0.00% | −14,815−100.0% | Sold out |
| ProShare Advisors LLC | 0 | $0 | 0.00% | −12,875−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −11,159−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −8,528−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −254−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −154−100.0% | Sold out |